This announcement is a separate document:
Cerebain Biotech Corp | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.